Monday, Nov 23 2020 | Time 14:40 Hrs(IST)
image
  • Covid-19 situation is grim, likely to worsen in December: Supreme Court
  • Russia registers new record of 25,173 COVID-19 cases in past 24 hours - Response Center
  • HAL develops modified IJT commences Spin Flight Testing
  • Controversial admendment to Kerala police act not be implemented : CM
  • Anti-Bru settlement movement in Tripura widens communal divide
  • AstraZeneca Covid vaccine can be 90 pc effective, data shows
  • SC extends parole of Rajiv Gandhi's assassin by one week
  • LB election: Two Muslim women to contest on BJP ticket
  • Oxford-AstraZeneca COVID-19 Vaccine Is Up to 90 per cent Effective - AstraZeneca
  • First Session of 17th Assembly begins, Ministers and MLAs take oath
  • National Capital continues to reel under 'poor' air quality
  • SC express concern over COVID situation, asks all states to file status reports
  • PM inaugurates multi-storeyed flats for MPs
  • India's Covid recovery rate sustains above 93 per cent
  • India clocks fresh spike of 44,059 COVID cases
WorldPosted at: Nov 23 2020 1:47PM


Oxford-AstraZeneca COVID-19 Vaccine Is Up to 90 per cent Effective - AstraZeneca

MOSCOW, Nov 23 (Sputnik) The AZD1222 COVID-19 vaccine, developed by the Oxford University and the AstraZeneca pharmaceutical giant, is up to 90 percent effective, according to results of interim analysis of the clinical trials in the United Kingdom and Brazil, AstraZeneca said on Monday, noting that the average efficacy is assessed at 70 percent.
No hospitalizations were reported in participants of the trials, according to AstraZeneca. Over 23,000 volunteers aged 18 and more are being assessed.
"One dosing regimen (n=2,741) showed vaccine efficacy of 90% when AZD1222 was given as a half dose, followed by a full dose at least one month apart, and another dosing regimen (n=8,895) showed 62% efficacy when given as two full doses at least one month apart. The combined analysis from both dosing regimens (n=11,636) resulted in an average efficacy of 70%," AstraZeneca said in a press release.
The pharmaceutical company added it would seek an emergency use listing from the World Health Organization " or an accelerated pathway to vaccine availability in low-income countries."
SPUTNIK GK 1347
Tags: #Oxford-AstraZeneca COVID-19 Vaccine Is Up to 90 per cent Effective - AstraZeneca
More News
US pulls out of Open Skies Treaty

US pulls out of Open Skies Treaty

23 Nov 2020 | 12:39 PM

Washington, Nov 23 (UNI) The US on Sunday pulled out of a 1992 arms control treaty allowing unarmed surveillance flights over the territories of member countries to build confidence and promote the transparency of military activities.

see more..
US President-elect Joe Biden to announce Cabinet on Tuesday

US President-elect Joe Biden to announce Cabinet on Tuesday

23 Nov 2020 | 11:16 AM

Washington, Nov 23 (UNI) US President-elect Joe Biden will officially announce his first cabinet appointments on Tuesday, two members of his transition team said.

see more..

G20 vows to ensure universal access to COVID-19 vaccines

22 Nov 2020 | 11:18 PM

Riyadh, Nov 22 (UNI) The G20 countries have vowed to work together to ensure universal access to COVID-19 vaccines, therapeutics and diagnostics, a final statement adopted on Sunday after a two-day G20 summit said.

see more..
Bangladesh records 2,060 COVID-19 cases, 38 more deaths

Bangladesh records 2,060 COVID-19 cases, 38 more deaths

22 Nov 2020 | 10:28 PM

Dhaka, Nov 22 (UNI) Bangladesh on Sunday recorded 2,060 more cases of the novel coronavirus, bringing the total to 4,47,343.

see more..
Paris accord intended to kill US economy, not save environment: Trump

Paris accord intended to kill US economy, not save environment: Trump

22 Nov 2020 | 9:11 PM

Washington, Nov 22 (UNI) US President Donald Trump defended his decision to pull his country out of the 2015 Paris Accords on environment by stating that the Accords would have been a severe blow to the US economy.

see more..
image